Sunday, September 20, 2026

Canopy Growth Stock Falls By 29% In The Last 21 Sessions

Canopy Growth Stock Falls By 29% In The Last 21 Sessions

Canopy Growth's (NASDAQ: CGC) shares recent performance has startled investors as its value plummeted by 29.35% over the last 21 sessions. The stock fell from $55 on July 11, 2023, to $39.39 by 23:21 EST, Monday evening, despite two back-to-back optimistic sessions. In contrast, NASDAQ displayed a reassuring stance, marking an increase of 0.12% to $858.87, maintaining the previous upward streak.

About Canopy Growth Corporation

Headquartered in Canada, Canopy Growth and its subsidiaries deliver expertise in the production, distribution, and sale of cannabis- and hemp-related merchandise. Their products cater to both recreational and medicinal users, with primary markets being Canada, the U.S., and Germany. Canopy's stock hit a low when it closed at sh.39 on Wednesday evening, representing a 91.73% dip from its 52-week high of .77. This record low signifies dwindling investor confidence.

Canopy's Current Economic Position

The company is grappling with profitability issues, as depicted by their negative Earnings Per Share (EPS) of 5.34 over the previous year and a Return on Equity (ROE) value of -151.11%. This data indicates that Canopy is operating at a loss concerning the shareholders' equity.

Stock's Potential Performance

The stochastic oscillator suggests that the company's stock prices have hit their historical limit, indicating an overbought market. The red flags don't stop here. Digging deeper into Canopy's financials reveals a 27.6% decrease in quarterly revenue year-on-year, plummeting to 402.9M over the last twelve months. Furthermore, the reported trading volume for Canopy Growth was noted at 18552003, which reflects a 21.38% reduction compared to its average volume of 21584700. This could imply dwindling trading activity amongst clients.

Implications for Investors

Given the financial strain and unfavorable market indicators, investors should proceed with caution when considering investment strategies in Canopy Growth. It would be prudent to closely monitor the market for signs of recovery or further declines over time.

More news about Canopy Growth (CGC).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Boom Hits a Fork: Slowdown Calls Clash with Capex Confidence as Markets Get Nervous
Dario Amodei's repeated calls for a global slowdown in frontier AI development, echoed by Microsoft's new humanist AI code of conduct and FTC antitrust caution, are being publicly rejected by Nvidia and Meta leadership even as hyperscaler spending draws fresh skeptical scrutiny (Wachter's analysis, Burry-style overbuilding worries) and weak guidance from Adobe and a post-slowdown-comment selloff in GE Vernova signal investor jitters. Meanwhile wealth and security effects of the AI race keep compounding — Zhang Yiming's fortune surging on AI-driven ByteDance value, a Chinese hacking firm weaponizing AI against stolen government secrets, and low-quality AI-generated products (an AI sitcom, a spam-flooding agent platform) fueling backlash even as adoption races ahead.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Berkshire Hathaway
Both facts report Berkshire Hathaway's cash position on 2026-01-01 with identical observation timestamps, but claim vastly different values: 380 billion USD vs 400 USD. These cannot both be true for the same entity at the same point in time. The magnitude of the discrepancy (a factor of ~10^9) rules out rounding, unit conversion, or methodological differences.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,982
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,982 facts checked against source5,299 source documents archived
Query this data → isubstrate.com